Phytochemicals in the Treatment of Patients with Depression: a Systemic Review

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2024 Dec 24

PMID 39717381

Authors

Natalia Picheta

Julia Piekarz

Karolina Danilowska

Karol Mazur

Halina Piecewicz-Szczesna

Agata Smolen

Affiliations

Soon will be listed here.

Abstract

Background: Depression is a complex mental disease whose incidence increases every year; 300 million people worldwide currently suffer from it. Women are more likely to suffer from depression, twice the rate as men. It is one of the few illnesses that can lead to suicide, which makes it very dangerous - currently, 700,000 people die from suicide and it is the 4th most common cause of death in people aged 15-29. The treatment strategies for depression is a big challenge for physicians, pharmacists, scientists and classic remedies cause many side effects. Therefore, natural phytotherapy with herbs can prove to be a good solution. Phytotherapy is a popular treatment method used for centuries in Chinese medicine or Ayurveda.

Materials And Methods: The study conducted a comprehensive database search PubMed, ClinicalKey and MedNar covered the years 2015 - 2024 to provide the most up-to-date data. 13 randomized controlled trials and 1 meta - analysis were included in the systematic review.

Results: Many plants show anti-inflammatory, antioxidant and cognitive enhancing effects, which are particularly important in depression. In the treatment of depression, plants such as , and . have proven to be effective. They show good effectiveness in human studies and alleviate the symptoms of depression. Herbal products can support classical pharmacotherapy, but this requires further research. Non-commercial clinical trials in the future should provide answers to research questions: at what stage of treatment of patients with MDD will the use of phytochemicals be most appropriate in terms of therapy efficacy and safety for the patient.

Conclusions: , and . in modern medicine can help improve the well-being of patients with depression. The use of herbs as an intervention was associated with a decrease in the concentration of proinflammatory cytokines and an overall improvement in the mood of patients. Further research should be undertaken into combining both therapies in order to improve patients' quality of life and reduce treatment costs.

References

Yang Y, Hsu P, Chen Y, Yang Y . Dynamic transcriptomic mA decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018; 28(6):616-624. PMC: 5993786. DOI: 10.1038/s41422-018-0040-8. View

Bazrafshan M, Jokar M, Shokrpour N, Delam H . The effect of lavender herbal tea on the anxiety and depression of the elderly: A randomized clinical trial. Complement Ther Med. 2020; 50:102393. DOI: 10.1016/j.ctim.2020.102393. View

Klier C, Schafer M, Schmid-Siegel B, Lenz G, Mannel M . St. John's wort (Hypericum perforatum)--is it safe during breastfeeding?. Pharmacopsychiatry. 2002; 35(1):29-30. DOI: 10.1055/s-2002-19832. View

Stuhec M, Hahn M, Taskova I, Bayraktar I, Fitzgerald I, Molitschnig L . Clinical pharmacy services in mental health in Europe: a commentary paper of the European Society of Clinical Pharmacy Special Interest Group on Mental Health. Int J Clin Pharm. 2023; 45(5):1286-1292. PMC: 10600282. DOI: 10.1007/s11096-023-01643-4. View

Sadeghi A, Ghorayshi F, Baghshahi H, Akbari H, Memarzadeh M, Taghizadeh M . The antidepressant effect of combined extracts of and supplementation in patients with depression symptoms: A randomized clinical trial. Avicenna J Phytomed. 2023; 13(4):328-337. PMC: 10474918. DOI: 10.22038/AJP.2023.21707. View

But V, Bulboaca A, Rus V, Ilyes T, Gherman M, Bolboaca S . Anti-inflammatory and antioxidant efficacy of lavender oil in experimentally induced thrombosis. Thromb J. 2023; 21(1):85. PMC: 10410829. DOI: 10.1186/s12959-023-00516-0. View

Ojea Ramos S, Feld M, Fustinana M . Contributions of extracellular-signal regulated kinase 1/2 activity to the memory trace. Front Mol Neurosci. 2022; 15:988790. PMC: 9580372. DOI: 10.3389/fnmol.2022.988790. View

Colucci-DAmato L, Speranza L, Volpicelli F . Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer. Int J Mol Sci. 2020; 21(20). PMC: 7589016. DOI: 10.3390/ijms21207777. View

Adell A . Brain NMDA Receptors in Schizophrenia and Depression. Biomolecules. 2020; 10(6). PMC: 7355879. DOI: 10.3390/biom10060947. View

10.

Sultana S, Munir N, Mahmood Z, Riaz M, Akram M, Rebezov M . Molecular targets for the management of cancer using Curcuma longa Linn. phytoconstituents: A Review. Biomed Pharmacother. 2021; 135:111078. DOI: 10.1016/j.biopha.2020.111078. View

11.

Osimo E, Baxter L, Lewis G, Jones P, Khandaker G . Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychol Med. 2019; 49(12):1958-1970. PMC: 6712955. DOI: 10.1017/S0033291719001454. View

12.

Sanchez-Vidana D, Po K, Fung T, Chow J, Lau W, So P . Lavender essential oil ameliorates depression-like behavior and increases neurogenesis and dendritic complexity in rats. Neurosci Lett. 2019; 701:180-192. DOI: 10.1016/j.neulet.2019.02.042. View

13.

Marti-Clua J . Incorporation of 5-Bromo-2'-deoxyuridine into DNA and Proliferative Behavior of Cerebellar Neuroblasts: All That Glitters Is Not Gold. Cells. 2021; 10(6). PMC: 8229392. DOI: 10.3390/cells10061453. View

14.

Edinoff A, Akuly H, Hanna T, Ochoa C, Patti S, Ghaffar Y . Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review. Neurol Int. 2021; 13(3):387-401. PMC: 8395812. DOI: 10.3390/neurolint13030038. View

15.

Lopresti A, Drummond P . Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study. J Affect Disord. 2016; 207:188-196. DOI: 10.1016/j.jad.2016.09.047. View

16.

Pitsikas N . L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for Schizophrenia Treatment?. Molecules. 2021; 26(5). PMC: 7956290. DOI: 10.3390/molecules26051237. View

17.

Chrubasik-Hausmann S, Vlachojannis J, McLachlan A . Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content. J Pharm Pharmacol. 2018; 71(1):129-138. DOI: 10.1111/jphp.12858. View

18.

Ghaderi A, Rasouli-Azad M, Vahed N, Banafshe H, Soleimani A, Omidi A . Clinical and metabolic responses to crocin in patients under methadone maintenance treatment: A randomized clinical trial. Phytother Res. 2019; 33(10):2714-2725. DOI: 10.1002/ptr.6445. View

19.

Dobrek L, Glowacka K . Depression and Its Phytopharmacotherapy-A Narrative Review. Int J Mol Sci. 2023; 24(5). PMC: 10003400. DOI: 10.3390/ijms24054772. View

20.

Hunt C, Cordeiro T, Suchting R, de Dios C, Cuellar Leal V, Soares J . Effect of immune activation on the kynurenine pathway and depression symptoms - A systematic review and meta-analysis. Neurosci Biobehav Rev. 2020; 118:514-523. PMC: 8087452. DOI: 10.1016/j.neubiorev.2020.08.010. View